Suraksha Diagnostic Reports Mixed Financial Results Amid Rising Interest Costs in June 2025
Suraksha Diagnostic reported its financial results for the quarter ending June 2025, highlighting record net sales of Rs 72.59 crore and an operating profit of Rs 23.75 crore. However, rising interest expenses, now at Rs 2.70 crore, pose challenges to the company's financial stability.
Suraksha Diagnostic has recently reported its financial results for the quarter ending June 2025, revealing a mix of performance indicators. The company achieved its highest net sales in the last five quarters, reaching Rs 72.59 crore, indicating a positive near-term sales trend. Additionally, the operating profit also peaked at Rs 23.75 crore, reflecting a favorable trend in operating profitability.However, the financial landscape is not without challenges. The profit before tax (PBT) showed growth, reaching Rs 11.56 crore, which is a notable increase compared to the average of the previous four quarters. Despite this, the company is facing rising interest costs, with quarterly interest expenses climbing to Rs 2.70 crore, marking the highest level in five quarters. This increase in interest expenses, which grew by 31.07% quarter on quarter, raises concerns about the company's borrowing levels.
As a result of these dynamics, Suraksha Diagnostic has experienced an adjustment in its evaluation, with its score reflecting a shift from -1 to -2 over the past three months.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
